The MedTech Podcast

Karandeep Singh Badwal
  • 5.0（7則評分）
  • 生命科學
  • 每月更新

The MedTech Podcast shares the journey behind the path of the people shaping the MedTech industry and its future. Join me as I connect with industry leaders, thought providers and innovators. Hosted by Karandeep Singh Badwal, Karandeep is a Quality & Regulatory Consultant specialising in the MedTech Industry. If you have any ideas for future episodes or would like to be on the podcast then feel free to connect with me via the links below Follow Karandeep on LinkedIn: https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube: https://www.youtube.com/c/KarandeepBadwal/

  1. #88 Hydrogel Tech and Lab Automation with Sinan Golhan: Hydrogel Robotics, Startup Fundraising and Battlefield Medicine

    9月1日

    #88 Hydrogel Tech and Lab Automation with Sinan Golhan: Hydrogel Robotics, Startup Fundraising and Battlefield Medicine

    Sinan Gölhan, Founder and CEO of GelTech is helping scientists develop life-saving hydrogel treatments faster through automation. From cancer-fighting gels to battlefield-ready biomaterials, Sinan’s journey fuses deep technical insight with an intensely personal mission. In this episode, we talk about why hydrogels, the “Jell-O of medicine”, are so important in modern biotech, and how Sinan’s frustration with repetitive lab work led him to build robotic systems to accelerate testing. He shares hard-won lessons from early fundraising, what labs get wrong about automation, and how he turned rejection into resilience. We also dive into the world of battlefield bleeding control, nanotech-based drug delivery, and the future of AI-driven materials science. Timestamps: [00:00:18] What Are Hydrogels and Why They Matter [00:02:30] A Personal Mission: Cancer, Family and Science [00:04:45] From Lab Frustration to Robotic Innovation [00:06:33] Fundraising Real Talk: Angels, Grants, and Grit [00:10:42] How GelTech’s Platform Actually Works [00:13:33] Hydrogels in Your Fridge and in the OR [00:14:54] Why Lab Automation Isn’t a Luxury [00:16:23] The Coming Wave of Smart Materials [00:20:11] Battlefield Nanotech: Bleeding Control with Gels [00:27:25] Advice to Founders: Obsession, Vision and Persistence Get in touch with Sinan - https://www.linkedin.com/in/sinan-g%C3%B6lhan-a49691b6/ Learn more about Exagen - https://www.geltechlabs.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    27 分鐘
  2. #87 Diagnosing the Undiagnosable with Dr. Brittany Partain: T-Cell Biomarkers, Clinical Trust and Women in Biotech

    8月5日

    #87 Diagnosing the Undiagnosable with Dr. Brittany Partain: T-Cell Biomarkers, Clinical Trust and Women in Biotech

    Dr. Brittany Partain, Associate Director of Clinical Affairs and Physician Education at Exagen has a background in biomedical engineering and a passion for problem-solving, Brittany has carved out a unique role at the intersection of diagnostics, clinical education and biotech innovation In this episode, we explore why autoimmune diseases like lupus and rheumatoid arthritis are so difficult to diagnose, and how Brittany is helping close that gap through physician education and the use of novel T-cell biomarkers. We also talk about building trust with clinicians, misconceptions around diagnostic tools, and the real challenges of advancing innovation in a field that’s historically lagging behind specialities like oncology. Finally, Brittany reflects on her journey as a female leader in MedTech, the importance of collaboration, and why passion matters when navigating a fast-paced, highly regulated industry Timestamps: [00:00:45] Why Autoimmune Diseases Are So Difficult to Diagnose [00:01:55] From Biomedical Engineering to Clinical Affairs [00:04:34] Why Rheumatology Has Lagged Behind [00:07:07] How T-Cell Biomarkers Work and What They Solve [00:09:18] What Autoimmune Diseases Are and How They Present [00:11:05] Common Misconceptions Among Clinicians [00:13:00] How Hospitals and Private Clinics React to New Tools [00:15:07] Building Clinical Trust Through Science [00:18:05] What Most People Don’t Know About Autoimmune Disease [00:21:58] Women in Biotech: Breaking Stereotypes and Leading Change Get in touch with Brittany - https://www.linkedin.com/in/brittany-d-partain Learn more about Exagen - https://exagen.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    29 分鐘
  3. #86 Sepsis, Speed and Saving Lives with Dr. Rolland Carlson: Gene Signatures, Clinical Trials, and the Future of Infection Detection

    7月22日

    #86 Sepsis, Speed and Saving Lives with Dr. Rolland Carlson: Gene Signatures, Clinical Trials, and the Future of Infection Detection

    Dr. Rolland “Rollie” Carlson, CEO of Immunexpress is a veteran of the molecular diagnostics space. With over 25 years of leadership across Abbott, WaferGen, Asuragen, and more, Rollie is now focused on solving one of healthcare’s most urgent crises: Sepsis. In this episode, we explore why sepsis, despite causing more than 48 million deaths annually remains so poorly understood and misdiagnosed. Rollie breaks down why early detection is so difficult, how gene expression profiling can finally distinguish between infectious and non-infectious inflammation and the real-world barriers to clinical trial design, FDA approval and physician adoption. We also cover military use cases, the lack of gold standards in sepsis diagnostics and what needs to change in how hospitals are incentivised to tackle this condition Timestamps: [00:00:26] Why Sepsis Remains Underdiagnosed Globally [00:01:42] What Sepsis Actually Is and Why It's So Deadly [00:03:14] Who’s Most at Risk: Age, Immunity, and Beyond [00:04:25] Detecting Sepsis Through Gene Expression [00:05:39] Why Blood Cultures Aren’t Enough Anymore [00:09:14] FDA Approval Without a Gold Standard: The Regulatory Maze [00:12:39] Sepsis Isn’t Always Bacterial and Why That Matters [00:15:20] How Physicians Are Reacting to New Molecular Tools [00:17:35] Beyond Sepsis: Expansion Into Infectious Diseases [00:18:57] From Marine Biologist to Diagnostics Pioneer Get in touch with Rollie - https://www.linkedin.com/in/rollie-carlson-ph-d-059074a/ Learn more about Immunexpress - https://immunexpress.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    30 分鐘
  4. #85 Under the Skin with Martin Burns: Bedsores, Biology-Based Prevention & The Hidden Cost of Inaction

    7月8日

    #85 Under the Skin with Martin Burns: Bedsores, Biology-Based Prevention & The Hidden Cost of Inaction

    Martin Burns, CEO of Bruin Biometrics is a former management consultant who worked with Deloitte and PwC and has also served as a guest lecturer at UCLA Anderson School of Management, where he taught entrepreneurship in biotechnology At Bruin, Martin is leading the charge to bring pressure injury (bedsore) prevention into the 21st century. Bedsores are entirely preventable yet remain one of the most under-discussed threats in hospitals today, especially among patients with darker skin tones who are often overlooked by traditional visual assessments In this episode, Martin explains why a biology-first approach is needed to tackle these “silent killers,” the major cultural and systemic hurdles to adoption, and why he believes sensor technology should become as routine as checking blood oxygen levels. We also explore investor skepticism, the importance of diverse clinical validation and the operational realities of implementing new technologies in hospitals without disrupting workflows Timestamps: [00:00:18] What Are Pressure Injuries and Why They’re Deadly [00:02:12] The Moment Martin Saw the Real Problem [00:03:58] The Biology of Subepidermal Moisture [00:06:53] Turning a Science Project into a Scalable Product [00:10:06] Why Traditional Risk Assessments Fail [00:12:41] Addressing Skin Tone Bias in Wound Care [00:17:14] From Skepticism to Adoption: Changing Clinical Culture [00:21:55] Beyond Bedsores: Future Sensor Applications [00:24:17] The Nurse Assistant That Frees Up Hours [00:26:52] Mountains, Gym Days & Recharging Outside Work Get in touch with Martin - https://www.linkedin.com/in/martin-burns-9391a57/ Learn more about Bruin - https://sem-scanner.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    28 分鐘
  5. #84 Fast-Tracking Clinical Trials with Julio G. Martinez-Clark: LATAM Strategy, FIH Studies & MedTech Market Access

    6月9日

    #84 Fast-Tracking Clinical Trials with Julio G. Martinez-Clark: LATAM Strategy, FIH Studies & MedTech Market Access

    Julio G. Martinez-Clark CEO of Bioaccess and President of IAOCR/GCSA Americas is a MedTech trailblazer helping startups accelerate First-in-Human (FIH) clinical trials across Latin America, with over 20 years of experience spanning healthcare, telecom and venture capital In this episode, we unpack why more MedTech companies are turning to LATAM for faster, more cost-effective trial execution. Julio shares how his Miami-based CRO helps deliver 58-day CE mark approvals, his experience supporting 100+ device startups and why time, not money, is the most precious currency for early-stage founders. We also touch on trial quality, regulatory strategy and why he believes Latin America will play a defining role in the next era of global MedTech innovation Timestamps: [00:00:47] Why LATAM Is the Next MedTech Trial Hub [00:02:21] The Problem with FIH Trials in the U.S. [00:04:42] How bioaccess® Reduces Approval Timelines by 70% [00:06:01] Strategic Sites, Patient Retention & CRO Infrastructure [00:08:17] Do LATAM Trials Hold Up to FDA & EU Scrutiny? [00:10:43] The Fundraising Pressure Behind Faster Clinical Results [00:12:22] Founder Mistakes in In-House Trial Management [00:14:11] Why LATAM May Overtake Eastern Europe in FIH Volume [00:17:26] Regulatory Standards, UNESCO, and Regional Quality [00:20:10] Julio Outside the Office: Family, Fitness & Podcasting Get in touch with Julio - https://www.linkedin.com/in/juliomartinezclark/ Learn more about Bioaccess - https://www.bioaccessla.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    29 分鐘
  6. #83 Frequencies, Fields and the Future of Wellness with Mark L. Fox: From NASA to Neuromodulation and PEMF Therapy

    5月19日

    #83 Frequencies, Fields and the Future of Wellness with Mark L. Fox: From NASA to Neuromodulation and PEMF Therapy

    Mark Fox founder and CEO of Resona Health is a former NASA space shuttle engineer turned wellness-tech entrepreneur. From designing spacecraft to pioneering wearable PEMF (Pulsed Electromagnetic Field) therapy, Mark brings a rare blend of hardcore engineering and holistic healthcare innovation In this episode, we dive deep into the world of energy medicine from the scientific foundations of PEMF and resonance frequency therapy to its real-world impact on mental clarity, emotional regulation and chronic pain. Mark also walks us through the uphill battle with FDA compliance, the hidden power of vagus nerve stimulation and the unexpected physics that connect hot air balloons to healthcare innovation. It's a fascinating mix of engineering, wellness tech and startup grit Timestamps: [00:00:35] From NASA to Neuromodulation: Mark’s Origin Story [00:03:05] What Is PEMF Therapy? Explaining the Basics [00:05:48] The New Vagus Nerve Device: Chest vs Neck Placement [00:08:40] Why Frequency > Voltage: Ditching Electrodes for Fields [00:11:22] How Resona Built a 98% Success Rate with Pocket PEMF [00:13:33] Frequency over Pharma: A Founder’s Clinical Pivot [00:16:02] The Compliance Trap: How the FDA Deals With Wellness Claims [00:18:50] Using GPTs for Regulatory Copywriting (and Staying Legal) [00:21:10] What the Body Teaches You When You Build for It [00:24:16] Life Outside of Resona: Flying, Sailing and Freedom to Tinker Get in touch with Mark - https://www.linkedin.com/in/mark-fox-ab589110/ & https://resona.health/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal

    31 分鐘
  7. #82 The 5 Pillars of MedTech Startup Success with Jón Ingi Bergsteinsson: MedTech SaaS, Clinical Trials and Commercial Strategy

    5月5日

    #82 The 5 Pillars of MedTech Startup Success with Jón Ingi Bergsteinsson: MedTech SaaS, Clinical Trials and Commercial Strategy

    Jón Ingi Bergsteinsson MedTech founder, former CTO of SMART-TRIAL and now a startup advisor and investor via LIFA Ventures. With 10+ years of hands-on experience scaling a SaaS company in regulated healthcare, Jón offers a rare blend of technical and commercial insight. In this episode, we talk about why founders should stop treating regulatory and commercial teams like separate planets, how VCs really evaluate MedTech startups, and what SaaS-style thinking can teach traditional device companies. Jón also walks us through his “founder-to-fund” journey, shares common pitfalls in clinical trial design and gives a blunt take on why copying pharma’s playbook won’t work in MedTech. Timestamps: [00:00:35] Why MedTech Startups Still Struggle to Scale [00:03:41] Building SMART-TRIAL Without Venture Capital [00:06:25] Regulatory & Clinical Teams Need to Talk More [00:09:50] LIFA Ventures: Investing Beyond the Spreadsheet [00:12:12] The Hidden Cost of Ignoring Commercialization [00:14:07] Copying Pharma? That’s a Mistake [00:17:33] Europe vs U.S. Startup Culture: What Founders Get Wrong [00:20:45] Advice for Early-Stage Founders in Regulated Health [00:24:28] Jón’s Life Beyond MedTech: Coaching, Family & Hobbies [00:26:12] One Thing He Wishes Founders Would Stop Doing Get in touch with Jón - https://www.linkedin.com/in/joningib/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    31 分鐘
  8. #81 Artificial Intelligence in Cardiology with Mark Goddard: Real-Time ECGs, Home Monitoring and the Atrial Fibrillation Crisis

    4月14日

    #81 Artificial Intelligence in Cardiology with Mark Goddard: Real-Time ECGs, Home Monitoring and the Atrial Fibrillation Crisis

    Mark Goddard, Vice President of Clinical Services at InfoBionic.Ai, a leading authority in cardiac remote monitoring. A registered nurse with over 20 years of experience in clinical electrophysiology, Mark has pioneered service lines across ambulatory ECG, cardiac event monitoring, mobile telemetry and heart failure management in hundreds of institutions. He’s also a certified Clinical Cardiac Device Specialist with deep knowledge of subcutaneous monitoring and AI-assisted diagnostics In this episode, we explore how AI and real-time ECG data are revolutionising arrhythmia detection, heart failure prediction and patient engagement especially for high-risk groups like those with A-Fib. Mark shares practical insights from the front lines of cardiac care, how to tell genuine innovation from AI hype and why the future of diagnostics may lie beyond traditional heart monitoring. We also cover clinical implementation challenges, device design for older populations and the fine line between wellness tracking and medical-grade care Timestamps: [00:00:27] AI-Powered ECG: From Novelty to Necessity [00:03:28] How Clinicians Are Separating Hype from Reality [00:05:07] Why Near Real-Time Beats Traditional ECG Monitoring [00:08:49] A-Fib and the Global Data Gap [00:11:36] When Good Tech Goes Bad: Early Pacemaker Mistakes [00:13:30] Hospitals, Homes and the Future of Cardiac Care [00:19:59] AI vs Machine Learning: What’s the Real Difference? Get in touch with Mark - https://www.linkedin.com/in/mark-goddard-035ab427/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

    30 分鐘
顯示全部 (88)

5
（滿分 5 顆星）
7 則評分

簡介

The MedTech Podcast shares the journey behind the path of the people shaping the MedTech industry and its future. Join me as I connect with industry leaders, thought providers and innovators. Hosted by Karandeep Singh Badwal, Karandeep is a Quality & Regulatory Consultant specialising in the MedTech Industry. If you have any ideas for future episodes or would like to be on the podcast then feel free to connect with me via the links below Follow Karandeep on LinkedIn: https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube: https://www.youtube.com/c/KarandeepBadwal/

資訊

  • 創作者
    Karandeep Singh Badwal
  • 活躍年代
    2021年 - 2025年
  • 集數
    88
  • 年齡分級
    兒少不宜
  • 版權
    © Karandeep Singh Badwal
  • 節目網站
    The MedTech Podcast